Chemotherapeutic Management of Stage IV Non-small Cell Lung Cancer*
Mark A. Socinski, David E. Morris, Gregory A. Masters et al. · CHEST Journal · 2003
Cited by 203 works. doi:10.1378/chest.123.1_suppl.226s
Authors
References
- Revisions in the International System for Staging Lung Cancer
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
- COMPARISON OF FOUR CHEMOTHERAPY REGIMENS FOR ADVANCED NON-SMALL-CELL LUNG CANCER
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
- Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.
- Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
- Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.